424 related articles for article (PubMed ID: 26502731)
41. Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression.
Zhang Y; Xu Y; Li F; Li X; Feng L; Shi X; Wang L; Li X
Oncotarget; 2016 May; 7(18):25769-82. PubMed ID: 27013589
[TBL] [Abstract][Full Text] [Related]
42. Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.
Akiyama Y; Komiyama M; Miyata H; Yagoto M; Ashizawa T; Iizuka A; Oshita C; Kume A; Nogami M; Ito I; Watanabe R; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Apr; 31(4):1683-90. PubMed ID: 24573400
[TBL] [Abstract][Full Text] [Related]
43. Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.
Sun G; Yan S; Shi L; Wan Z; Jiang N; Li M; Guo J
Cancer Biother Radiopharm; 2015 May; 30(4):169-73. PubMed ID: 25811315
[TBL] [Abstract][Full Text] [Related]
44. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
45. High level of Sema3C is associated with glioma malignancy.
Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
[TBL] [Abstract][Full Text] [Related]
46. Identification of differentially expressed genes and fusion genes associated with malignant progression of spinal cord gliomas by transcriptome analysis.
Liu DK; Wang J; Guo Y; Sun ZX; Wang GH
Sci Rep; 2019 Sep; 9(1):13583. PubMed ID: 31537867
[TBL] [Abstract][Full Text] [Related]
47. Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.
Maimaiti A; Wang X; Hao Y; Jiang L; Shi X; Pei Y; Feng Z; Kasimu M
J Mol Neurosci; 2021 Aug; 71(8):1622-1635. PubMed ID: 33713320
[TBL] [Abstract][Full Text] [Related]
48. Regulatory landscape and clinical implication of MBD3 in human malignant glioma.
Cui Y; Li J; Weng L; Wirbisky SE; Freeman JL; Liu J; Liu Q; Yuan X; Irudayaraj J
Oncotarget; 2016 Dec; 7(49):81698-81714. PubMed ID: 27835581
[TBL] [Abstract][Full Text] [Related]
49. Deregulated expression of the clock genes in gliomas.
Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
[TBL] [Abstract][Full Text] [Related]
50. Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma.
Hu H; Wang Z; Li M; Zeng F; Wang K; Huang R; Wang H; Yang F; Liang T; Huang H; Jiang T
Sci Rep; 2017 Sep; 7(1):11568. PubMed ID: 28912488
[TBL] [Abstract][Full Text] [Related]
51. m
Chai RC; Wu F; Wang QX; Zhang S; Zhang KN; Liu YQ; Zhao Z; Jiang T; Wang YZ; Kang CS
Aging (Albany NY); 2019 Feb; 11(4):1204-1225. PubMed ID: 30810537
[TBL] [Abstract][Full Text] [Related]
52. Adaptor Protein Complex 1 Sigma 3 Is Highly Expressed in Glioma and Could Enhance Its Progression.
Ye T; Cheng Y; Li C
Comput Math Methods Med; 2021; 2021():5086236. PubMed ID: 34367317
[TBL] [Abstract][Full Text] [Related]
53. Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.
Coppola D; Balducci L; Chen DT; Loboda A; Nebozhyn M; Staller A; Fulp WJ; Dalton W; Yeatman T; Brem S
J Geriatr Oncol; 2014 Oct; 5(4):389-99. PubMed ID: 25220188
[TBL] [Abstract][Full Text] [Related]
54. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
[TBL] [Abstract][Full Text] [Related]
56. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
Han Z; Jia J; Lv Y; Wang R; Cao K
Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
[TBL] [Abstract][Full Text] [Related]
57. Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.
Azevedo H; Fujita A; Bando SY; Iamashita P; Moreira-Filho CA
PLoS One; 2014; 9(11):e110934. PubMed ID: 25365520
[TBL] [Abstract][Full Text] [Related]
58. PLEKHG5 is a novel prognostic biomarker in glioma patients.
Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
[TBL] [Abstract][Full Text] [Related]
59. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
60. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.
Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ
Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
